FDA Updates Potency Rules for Cell and Gene Therapies Replacing guidance from 2011, the FDA's updated framework emphasizes potency assurance throughout cell and gene therapy development and manufacturing November 11, 2026 3 min The Medicine Maker Share Summary Takeaways Listen Quiz Poll
